The results that ASV activated FOXO3a in TGF‐β1‐induced EMT via inhibition of PI3K/Akt pathway mechanically explained the inhibitory role of ASV in pulmonary fibrosis fibrogenesis and indicated that ASV could be served as a potential therapeutic strategy for IPF. The gene discussed is FOXO3; the disease is idiopathic pulmonary fibrosis.